A strategic framework for synergizing managed entry agreement efforts to access pharmaceutical products in Saudi Arabia—results from a multi-stakeholder workshop

In Saudi Arabia, MEAs are perceived as strategic levers to enable health system to navigate the access paradox, particularly for innovative and high-cost therapies. Nevertheless, having in place a robust Saudi-specific framework and anchored regulations and policies is essential to ensure that MEAs enhance-rather than compromise-access, sustainability, and equity. As therapies grow more complex, Saudi Arabia must adopt agile, evidence-adaptive MEAs policy and structure to remain fit for purpose.

Authors

Institutions

Publication Details

Journal
Journal of Medical Economics
Published
2025-05-15
DOI
https://doi.org/10.1080/13696998.2025.2506967
Citations
1
Primary Topic
Pharmaceutical Economics and Policy
Type
article
Field-Weighted Citation Impact
3.13
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

A strategic framework for synergizing managed entry agreement efforts to access pharmaceutical products in Saudi Arabia—results from a multi-stakeholder workshop

Rosanna Tarricone, Khalid Mohammed Alyahya, Mansoor Ahmed Khan, Laila Carolina Abu Esba et al.
1 citations
Journal of Medical Economics
Pharmaceutical Economics and Policy
3.13
article

A strategic framework for synergizing managed entry agreement efforts to access pharmaceutical products in Saudi Arabia—results from a multi-stakeholder workshop

Rosanna Tarricone, Khalid Mohammed Alyahya, Mansoor Ahmed Khan, Laila Carolina Abu Esba, Esraa Altawil, Jaime Espín, Panos G. Kanavos, Amal Hassan Al-Najjar, Fatma Maraiki, Consuela Cheriece Yousef, Hussain Abdulrahman Al‐Omar, Hind Almodaimegh, Jehan Alamre, Asma Abdulaziz Al-Muhsin, Lolwa Hamad Almudaiyan
article en
1 citations

Abstract

In Saudi Arabia, MEAs are perceived as strategic levers to enable health system to navigate the access paradox, particularly for innovative and high-cost therapies. Nevertheless, having in place a robust Saudi-specific framework and anchored regulations and policies is essential to ensure that MEAs enhance-rather than compromise-access, sustainability, and equity. As therapies grow more complex, Saudi Arabia must adopt agile, evidence-adaptive MEAs policy and structure to remain fit for purpose.

Journal of Medical EconomicsVol. 28(1)
Department of Health and Social Care (GB), Riyadh Armed Forces Hospital (SA), King Abdulaziz University (SA), King Saud bin Abdulaziz University for Health Sciences (SA), King Faisal Specialist Hospital & Research Centre (SA), King Saud Medical City (SA), Ministero della Salute (IT), King Saud University (SA), King Abdulaziz Medical City (SA), King Abdullah International Medical Research Center (SA), National Guard Health Affairs (SA), Andalusian School of Public Health (ES), Bocconi University (IT)
Partnerships for the goals
Openalex Percentile: Top 8%
Pharmaceutical Economics and Policy
3.13
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.